Evidence map›Paper›PMID 27399773›Full record

ReviewToxins2016

Regulation of Toxin Production in Clostridium perfringens.

Kaori Ohtani, Tohru Shimizu

Open access · goldAbstract readReview
In one paragraph

Review in Toxins, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 84 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Epidemiological and Metabolic Characteristics ofAnimals : an open access journal from MDPI · 2026
    Article
  5. Article
  6. Genomic and clinical determinants of extraintestinalmedRxiv : the preprint server for health sciences · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The Lreu_1276 protein fromApplied and environmental microbiology · 2024
    Article
  12. Review
  13. Isolation of a VirulentCurrent issues in molecular biology · 2024
    Article
  14. Open veterinary journal · 2024
    Article
  15. Evaluation of Immunogenicity ofArchives of Razi Institute · 2023
    Article
  16. Review
  17. Article
  18. Article
  19. Piceatannol AlleviatesMolecules (Basel, Switzerland) · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Kaori OhtaniMiyarisan Pharmaceutical Co., Ltd., 1-10-3, Kaminakazato, Kita-ku, Tokyo 114-0016, Japan. k.ohtani@miyarisan.com.
Tohru ShimizuDepartment of Bacteriology, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-machi, Kanazawa, Ishikawa 920-8640, Japan.
Kanazawa University · JPNippon Zoki (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Gram-positive anaerobic bacterium Clostridium perfringens is widely distributed in nature, especially in soil and the gastrointestinal tracts of humans and animals. C. perfringens causes gas gangrene and food poisoning, and it produces extracellular enzymes and toxins that are thought to act synergistically and contribute to its pathogenesis. A complicated regulatory network of toxin genes has been reported that includes a two-component system for regulatory RNA and cell-cell communication. It is necessary to clarify the global regulatory system of these genes in order to understand and treat the virulence of C. perfringens. We summarize the existing knowledge about the regulatory mechanisms here.

Indexed as

Bacterial ProteinsBacterial ToxinsClostridium perfringensGene Expression Regulation, BacterialHost-Pathogen InteractionsVirulenceBacterial ProteinsBacterial ToxinsC. perfringensregulatory network

Identifiers

PMID27399773
PMCPMC4963840
OpenAlexW2467190568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.